Excelsior Correspondent
JAMMU, June 8: In a groundbreaking move for diabetes treatment and care, Dr Abhinav Gupta, Professor Medicine ASCOMS and Hospital has inked a Memorandum of Understanding (MoU) with Actxa, a Singapore-based AI-Driven Deep Tech Company, for a strategic collaboration for research work on AI powered Blood Glucose Evaluation and Monitoring (BGEM).
At the heart of this partnership is Actxa’s groundbreaking BGEM -the world’s first non-invasive blood glucose monitoring technology.
Harnessing the power of AI, wearable technologies and signal processing, BGEM tracks and identifies the risk of impaired glucose regulation.
The partnership aims to spearhead the development of a pioneering non-invasive blood glucose monitoring solution leveraging Artificial Intelligence (AI). This innovative technology, powered by an AI-driven algorithm, promises to offer a paradigm shift in blood glucose evaluation and monitoring.
Follow our WhatsApp channel